Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wadelius, Mia"'
Autor:
Cismaru AL; Department of Clinical Chemistry, Inselspital Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland., Rudin D; Department of Clinical Pharmacology & Toxicology, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.; Department of Biomedicine, University of Basel, 4051 Basel, Switzerland., Ibañez L; Clinical Pharmacology Service, Hospital Universitari Vall d'Hebron, Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, Fundació Institut Català de Farmacología, 08035 Barcelona, Spain., Liakoni E; Department of Clinical Pharmacology & Toxicology, Inselspital Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Institute of Pharmacology, University of Bern, 3012 Bern, Switzerland., Bonadies N; Department of Hematology and Central Hematology Laboratory, Inselspital Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Kreutz R; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Klinische Pharmakologie und Toxikologie, 10117 Berlin, Germany., Carvajal A; Centro de Estudios sobre la Seguridad de los Medicamentos, Universidad de Valladolid, 47005 Valladolid, Spain., Lucena MI; Servicio Farmacologia Clinica, Instituto de Investigación Biomedica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, 29010 Málaga, Spain., Martin J; Instituto de Parasitología y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Cientiíficas, 18016 Granada, Spain., Sancho Ponce E; Servei d'Hematologia i Banc de Sang, Hospital General de Catalunya, 08190 Sant Cugat del Vallès, Spain., Molokhia M; Department of Population Health Sciences, King's College London, London WC2R 2LS, UK., Eriksson N; Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden., EuDAC Collaborators, Krähenbühl S; Department of Clinical Pharmacology & Toxicology, University Hospital Basel, University of Basel, 4031 Basel, Switzerland., Largiadèr CR; Department of Clinical Chemistry, Inselspital Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Haschke M; Department of Clinical Pharmacology & Toxicology, Inselspital Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Institute of Pharmacology, University of Bern, 3012 Bern, Switzerland., Hallberg P; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden., Wadelius M; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden., Amstutz U; Department of Clinical Chemistry, Inselspital Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Publikováno v:
Genes [Genes (Basel)] 2020 Oct 29; Vol. 11 (11). Date of Electronic Publication: 2020 Oct 29.
Autor:
Wadelius M; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Eriksson N; Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Kreutz R; Charité - Universitätsmedizin Berlin, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany., Bondon-Guitton E; Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire, Faculté de Médecine de l'Université de Toulouse, Toulouse, France., Ibañez L; Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Fundació Institut Català de Farmacologia, Barcelona, Spain., Carvajal A; Centro de Estudios sobre la Seguridad de los Medicamentos, Universidad de Valladolid, Valladolid, Spain., Lucena MI; S Farmacologia Clinica, Instituto de Investigación Biomedica de Málaga (IBIMA), H Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd, Madrid, Spain., Sancho Ponce E; Servei d'Hematologia i Banc de Sang, Hospital General de Catalunya, Sant Cugat del Vallès, Spain., Molokhia M; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London Department of Primary Care and Public Health Sciences, London, UK., Martin J; Instituto de Parasitologia y Biomedicina Lopez-Neyra, CSIC, Granada, Spain., Axelsson T; Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Kohnke H; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Yue QY; Medical Products Agency, Uppsala, Sweden., Magnusson PKE; Swedish Twin Registry, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Bengtsson M; Department of Immunology, Genetics and Pathology, Clinical Immunology, Uppsala University, Uppsala, Sweden., Hallberg P; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2018 May; Vol. 103 (5), pp. 843-853. Date of Electronic Publication: 2017 Sep 28.
Autor:
Hallberg P; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Eriksson N; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Ibañez L; Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Fundació Institut Català de Farmacologia, Barcelona, Spain., Bondon-Guitton E; Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire, Faculté de Médecine de l'Université de Toulouse, Toulouse, France., Kreutz R; Institut für Klinische Pharmakologie und Toxikologie, Charité-Universitätsmedizin Berlin, Berlin, Germany., Carvajal A; Centro de Estudios sobre la Seguridad de los Medicamentos, Universidad de Valladolid, Valladolid, Spain., Lucena MI; S Farmacologia Clinica, Instituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain., Ponce ES; Servei d'Hematologia i Banc de Sang, Hospital General de Catalunya, Sant Cugat del Vallès, Spain., Molokhia M; Department of Primary Care and Public Health Sciences, National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Martin J; Instituto de Parasitologia y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain., Axelsson T; Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Yue QY; Medical Products Agency, Uppsala, Sweden., Magnusson PK; Swedish Twin Registry, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden., Wadelius M; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. Electronic address: mia.wadelius@medsci.uu.se.
Publikováno v:
The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2016 Jun; Vol. 4 (6), pp. 507-16. Date of Electronic Publication: 2016 May 03.
Autor:
Wadelius, Mia, Eriksson, Niclas, Kreutz, Reinhold, Bondon‐Guitton, Emmanuelle, Ibañez, Luisa, Carvajal, Alfonso, Lucena, M. Isabel, Sancho Ponce, Esther, Molokhia, Mariam, Martin, Javier, Axelsson, Tomas, Kohnke, Hugo, Yue, Qun‐Ying, Magnusson, Patrik K.E., Bengtsson, Mats, Hallberg, Pär
Publikováno v:
Wadelius, M, Eriksson, N, Kreutz, R, Bondon-Guitton, E, Ibañez, L, Carvajal, A, Lucena, M I, Sancho Ponce, E, Molokhia, M, Martin, J, Axelsson, T, Kohnke, H, Yue, QY, Magnusson., P K E & Bengtsson, M & Hallberg, P 2018, ' Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus ', Clinical Pharmacology and Therapeutics, vol. 103, no. 5, pp. 843-853 . https://doi.org/10.1002/cpt.805
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics
Agranulocytosis is a serious, although rare, adverse reaction to sulfasalazine, which is used to treat inflammatory joint and bowel disease. We performed a genome‐wide association study comprising 9,380,034 polymorphisms and 180 HLA alleles in 36 c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5568ead9907a0abde9cf02aa3a9b2583
https://kclpure.kcl.ac.uk/en/publications/396386dd-3c25-44d3-9af3-02c4ab55fdfc
https://kclpure.kcl.ac.uk/en/publications/396386dd-3c25-44d3-9af3-02c4ab55fdfc
Autor:
Wadelius, Mia, Eriksson, Niclas, Kreutz, Reinhold, Bondon-Guitton, Emmanuelle, Ibáñez, Luisa, Carvajal, Alfonso, Lucena, M. Isabel, Sancho Ponce, Esther, Molokhia, Mariam, Martin Martinez, Javier, Axelsson, Tomas, Kohnke, Hugo, Yue, Qun-Ying, Magnusson, Patrik K. E., Bengtsson, Mats, Hallberg, Pär, Universitat Autònoma de Barcelona
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Universitat Autònoma de Barcelona
Agranulocytosis is a serious, although rare, adverse reaction to sulfasalazine, which is used to treat inflammatory joint and bowel disease. We performed a genome-wide association study comprising 9,380,034 polymorphisms and 180 HLA alleles in 36 cas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::844383489d8fb8a52b8363ce2ed99349
Wiley Online Library
Wiley Online Library
Autor:
Cismaru, Anca Liliana, Grimm, Livia, Rudin, Deborah, Ibañez, Luisa, Liakoni, Evangelia, Bonadies, Nicolas, Kreutz, Reinhold, Hallberg, Pär, Wadelius, Mia, Haschke, Manuel, Largiadèr, Carlo R., Amstutz, Ursula
Publikováno v:
Frontiers in Genetics; 8/21/2020, Vol. 11, pN.PAG-N.PAG, 15p
Publikováno v:
BMC Blood Disorders; 2004, Vol. 4, p1-6, 6p, 2 Diagrams, 2 Charts, 1 Graph